Home/Filings/4/0001209191-17-037112
4//SEC Filing

Insys Therapeutics, Inc. 4

Accession 0001209191-17-037112

CIK 0001516479operating

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 3:14 PM ET

Size

5.0 KB

Accession

0001209191-17-037112

Insider Transaction Report

Form 4
Period: 2017-06-01
Transactions
  • Purchase

    Common Stock

    2017-06-01$14.14/sh+4,000$56,5754,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.14 to $14.145, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Issuer

Insys Therapeutics, Inc.

CIK 0001516479

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001516479

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 3:14 PM ET
Size
5.0 KB